Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32:605–44.

Article  PubMed  Google Scholar 

Domagala-Kulawik J, Trojnar A. Lung cancer in women in 21th century. J Thorac Dis. 2020;12:4398–410.

Article  PubMed  PubMed Central  Google Scholar 

Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30:R921–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chai X, Zhang X, Li W, Chai J. Small cell lung cancer transformation during anti-tumor therapies: a systematic review. Open Med (Wars). 2021;16:1160–7.

Article  PubMed  Google Scholar 

Khodabakhshi Z, Mostafaei S, Arabi H, Oveisi M, Shiri I, Zaidi H. Non-small cell lung carcinoma histopathological subtype phenotyping using high-dimensional multinomial multiclass CT radiomics signature. Comput Biol Med. 2021;136: 104752.

Article  CAS  PubMed  Google Scholar 

Johnson JL, Pillai S, Chellappan SP. Genetic and biochemical alterations in non-small cell lung cancer. Biochem Res Int. 2012;2012: 940405.

Article  PubMed  PubMed Central  Google Scholar 

Dhamija S, Menon MB. Non-coding transcript variants of protein-coding genes—what are they good for? RNA Biol. 2018;15:1025–31.

PubMed  PubMed Central  Google Scholar 

Cagle PT, Allen TC, Olsen RJ. Lung cancer biomarkers: present status and future developments. Arch Pathol Lab Med. 2013;137:1191–8.

Article  CAS  PubMed  Google Scholar 

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Mol Diagn. 2013;15:415–53.

Article  CAS  PubMed  Google Scholar 

Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Mol Diagn. 2018;20:129–59.

Article  CAS  PubMed  Google Scholar 

Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703–40.

Article  PubMed  PubMed Central  Google Scholar 

Raniszewska A, Kwiecień I, Rutkowska E, Rzepecki P, Domagała-Kulawik J. Lung cancer stem cells-origin, diagnostic techniques and perspective for therapies. Cancers (Basel) 2021;13.

Guzel E, Okyay TM, Yalcinkaya B, Karacaoglu S, Gocmen M, Akcakuyu MH. Tumor suppressor and oncogenic role of long non-coding RNAs in cancer. North Clin Istanb. 2020;7:81–6.

PubMed  Google Scholar 

Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 2018;32:868–902.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pertea M. The human transcriptome: an unfinished story. Genes (Basel). 2012;3:344–60.

Article  CAS  PubMed  Google Scholar 

Diamantopoulos MA, Tsiakanikas P, Scorilas A. Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer. Ann Transl Med. 2018;6:241.

Article  PubMed  PubMed Central  Google Scholar 

Razlansari M, Jafarinejad S, Rahdar A, Shirvaliloo M, Arshad R, Fathi-Karkan S, Mirinejad S, Sargazi S, Sheervalilou R, Ajalli N. Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer. Mol Cell Biochem. 2023;478:1573–98.

Article  CAS  PubMed  Google Scholar 

Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 2022;23:389–406.

Article  CAS  PubMed  Google Scholar 

Dey S, Fan C, Gothelf KV, Li J, Lin C, Liu L, Liu N, Nijenhuis MA, Saccà B, Simmel FC. DNA origami. Nat Rev Methods Primers. 2021;1:13.

Article  Google Scholar 

Abramowicz A, Story MD. The long and short of it: the emerging roles of non-coding RNA in small extracellular vesicles. Cancers. 2020;12:1445.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X-Z, Liu H, Chen S-R. Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers. 2020;12:1245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L-L. Towards higher-resolution and in vivo understanding of lncRNA biogenesis and function. Nat Methods. 2022;19:1152–5.

Article  CAS  PubMed  Google Scholar 

Sato M, Kadomatsu T, Miyata K, Warren JS, Tian Z, Zhu S, Horiguchi H, Makaju A, Bakhtina A, Morinaga J. The lncRNA Caren antagonizes heart failure by inactivating DNA damage response and activating mitochondrial biogenesis. Nat Commun. 2021;12:2529.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Ding W, Yu W, Zhang Y, Ao X, Wang J. Long non-coding RNAs: biogenesis, functions, and clinical significance in gastric cancer. Molecular Therapy-Oncolytics. 2021;23:458–76.

Article  PubMed  PubMed Central  Google Scholar 

Shah IM, Dar MA, Bhat KA, Dar TA, Ahmad F, Ahmad SM. Long non-coding RNAs: biogenesis, mechanism of action and role in different biological and pathological processes. 2022. Available from: https://doi.org/10.5772/intechopen.104861

Jensen S, Brasset E, Parey E, Roest Crollius H, Sharakhov IV, Vaury C. Conserved small nucleotidic elements at the origin of concerted piRNA biogenesis from genes and lncRNAs. Cells. 2020;9:1491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCool MA, Bryant CJ, Baserga SJ. MicroRNAs and long non-coding RNAs as novel regulators of ribosome biogenesis. Biochem Soc Trans. 2020;48:595–612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chao H, Hu Y, Zhao L, Xin S, Ni Q, Zhang P, Chen M. Biogenesis, functions, interactions, and resources of non-coding RNAs in plants. Int J Mol Sci. 2022;23:3695.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehmandar-Oskuie A, Jahankhani K, Rostamlou A, Arabi S, Razavi ZS, Mardi A. Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies. Biomed Pharmacother. 2023;165: 115242.

Article  CAS  PubMed  Google Scholar 

Klapproth C, Sen R, Stadler PF, Findeiß S, Fallmann J. Common features in lncRNA annotation and classification: a survey. Non-coding RNA. 2021;7:77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao R, Cui L, Zhang J, Ren X, Cheng B, Xia J. Immune-related lncRNA classification of head and neck squamous cell carcinoma. Cancer Cell Int. 2022;22:1–12.

Article  Google Scholar 

Chantsalnyam T, Lim DY, Tayara H, Chong KT. ncRDeep: non-coding RNA classification with convolutional neural network. Comput Biol Chem. 2020;88: 107364.

Article  CAS  PubMed  Google Scholar 

Yousefi H, Maheronnaghsh M, Molaei F, Mashouri L, Reza Aref A, Momeny M, Alahari SK. Long non-coding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39:953–74.